Providence, RI, Oct. 31, 2002 -- Kaldnes North America's patented Moving Bed™ Biofilm Reactor (MBBR) has been proven to achieve dramatic reductions in biochemical oxygen demand (BOD) and chemical oxygen demand (COD) in municipal and industrial applications, the company announced.
This system is a high rate, fixed film process resulting in a plant footprint that is 20% smaller than a conventional activated sludge plant. This gives the customer the capability to retrofit existing tankage and triple the treatment capacity.
MBBR applications are found in the municipal (for nitrification and denitrification), chemical, petrochemical, pharmaceutical, pulp and paper, food and dairy industries where waste loading conditions are widely variable.
The process can be used to retrofit existing wastewater treatment plants for increasing treatment capacity and/or meeting new effluent guidelines with respect to ammonia and total nitrogen without adding any extra tankage.
The MBBR process utilizes thousands of tiny, polyethylene biofilm elements to provide a home for a vast, highly active bacteria culture. These buoyant elements are kept in constant motion throughout the entire volume of the reactor, resulting in uniform, highly effective treatment.
Kaldnes is an international provider of biological treatment systems. The company offers experienced personnel in the MBBR field for the biological wastewater treatment and supplies its products through a network of sales representatives around the world.
For more information about Kaldnes' products and capabilities, visit their website at www.kaldnes.com.
Source: Kaldnes
